CLINICAL_TRIALS
trial_result
· 2015-10-09
Clinical Trial Update: Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 study of Secukinumab in newly diagnosed Type 1 Diabetes Mellitus was terminated, with results subsequently posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2015-10-09